China’s National Health Service (NHS) is testing herbal medicine products in an effort to prevent coronavirus (COVID) deaths and cases, according to Chinese media.
The Chinese Ministry of Health and Family Planning has launched a trial in Shanghai to evaluate herbal medicine’s safety and efficacy in COVID-19 patients.
The trial is aimed at identifying the efficacy of some herbal products for treating COVID symptoms, according a news report published on the ministry’s website.NHS in China has also launched a similar trial to test the safety and effectiveness of herbal medicines for people in West Africa and the Middle East, according the report.
The trials are being conducted at two centers: a small rural facility and a larger city facility.
The health service said it has collected data on a total of 4,935 patients with respiratory illnesses who have tested positive for COVID, and it will continue to conduct clinical trials for a further 4,000 people.
The health service is also working to determine the number of patients who have developed respiratory illnesses and who should be treated with herbal medicines, according reports.
Health officials have reported that the government is using “tough and appropriate measures” to prevent the spread of COVID and other diseases, according an official statement.
The trial will be completed by the end of the year.